Thymosin Alpha-1 is approved in other countries for certain cancers and immune-related conditions
This finding has clinical relevance for: Diabetic ulcers Pressure sores Surgical wound dehiscence Radiation-induced skin damage Chemical and thermal burns In practice, BPC-157 can be administered topically (in compounded creams), locally (via injection into wound margins), or systemically (subcutaneous injection) depending on the wound type and location
If just one element is out of place, Kennedy says, the compounded drug could have different effects or toxicities
Thats not a good enough reason for me
It is not a drug, food, cosmetic, or dietary supplement, and has not been evaluated by the FDA
5 reviews for AOD-9604 Peptide (10MG) Customer support was responsive